NeuroPace (NPCE) Debt Ratio (2020 - 2026)
NeuroPace (NPCE) posted quarterly Debt Ratio of 0.6 for Q1 2026, up 10.0% year-over-year from 0.54 in Q1 2025, and up 6.99% quarter-over-quarter from 0.56 in Q4 2025.
NeuroPace (NPCE) Debt Ratio (2020 - 2026) Analysis & Trends
NeuroPace's Debt Ratio history runs 7 years deep, the most recent figure standing at 0.6 for Q1 2026.
- In Q1 2026, Debt Ratio rose 10.0% year-over-year to 0.6; the TTM figure through Mar 2026 stood at 0.6 (up 10.0% YoY), while the FY2025 annual figure was 0.56, down 11.31% from the prior year.
- Debt Ratio for Q1 2026 stood at 0.6, up from 0.56 in the prior quarter.
- The five-year high for Debt Ratio was 0.63 in Q4 2024, with the low at 0.39 in Q1 2022.
- The 5-year median for Debt Ratio is 0.55 (2025), against an average of 0.54.
- The sharpest annual moves came in 2022 and 2023: Debt Ratio slumped 63.21% in 2022, then surged 30.51% in 2023.
- NeuroPace's Debt Ratio stood at 0.46 in 2022, then grew by 14.09% to 0.53 in 2023, then advanced by 18.87% to 0.63 in 2024, then slipped by 11.31% to 0.56 in 2025, then grew by 6.99% to 0.6 in 2026.
- Business Quant data shows NPCE's Debt Ratio at 0.6 in Q1 2026, 0.56 in Q4 2025, and 0.55 in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Debt Ratio (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 200.51 Bn | 194.91 Bn | 7.27 Bn | 0.30 |
| 2 | Stryker | 129.96 Bn | 126.48 Bn | 4.50 Bn | 0.31 |
| 3 | Medtronic | 120.18 Bn | 110.96 Bn | 6.41 Bn | 0.30 |
| 4 | Boston Scientific | 74.28 Bn | 73.74 Bn | 3.85 Bn | 0.28 |
| 5 | Edwards Lifesciences | 52.75 Bn | 48.50 Bn | 1.35 Bn | 0.04 |
| 6 | Dexcom | 34.67 Bn | 32.73 Bn | 830.00 Mn | - |
| 7 | GE HealthCare Technologies | 34.23 Bn | 32.12 Bn | 2.18 Bn | 0.27 |
| 8 | Koninklijke Philips | 26.46 Bn | 23.14 Bn | 4.55 Bn | 0.28 |
| 9 | Steris | 23.30 Bn | 22.82 Bn | 684.20 Mn | 0.18 |
| 10 | NeuroPace | 476.95 Mn | 425.25 Mn | 18.91 Mn | 0.61 |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 0.61 |
| Mar 31, 2026 | 0.60 |
| Dec 31, 2025 | 0.56 |
| Sep 30, 2025 | 0.55 |
| Jun 30, 2025 | 0.55 |
| Mar 31, 2025 | 0.54 |
| Dec 31, 2024 | 0.63 |
| Sep 30, 2024 | 0.62 |
| Jun 30, 2024 | 0.63 |
| Mar 31, 2024 | 0.59 |
| Dec 31, 2023 | 0.53 |
| Sep 30, 2023 | 0.56 |
| Jun 30, 2023 | 0.54 |
| Mar 31, 2023 | 0.51 |
| Dec 31, 2022 | 0.46 |
| Sep 30, 2022 | 0.43 |
| Jun 30, 2022 | 0.43 |
| Mar 31, 2022 | 0.39 |
| Dec 31, 2021 | 0.37 |
| Sep 30, 2021 | 0.35 |